Association of functionally different RUNX2 P2 promoter alleles with BMD

Journal of Bone and Mineral Research

Volumn 21, Issue 2, 2006, Pages 265-273

  Doecke, James D ^a   Day, Christopher J ^a   Stephens, Alexandre S J ^a   Carter, Shea L ^b   Van Daal, Angela ^b   Kotowicz, Mark A ^c   Nicholson, Geoff C ^c   Morrison, Nigel A ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Allelic variation; BMD; P2 promoter; RUNX2; Single nucleotide polymorphism

Indexed keywords

DNA; LUCIFERASE; TRANSCRIPTION FACTOR RUNX2;

ALLELE; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMUR NECK; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE INDUCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MOLECULAR CLONING; OSTEOBLAST; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; RUNX2 P2 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BONE DENSITY; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DENSITOMETRY, X-RAY; FEMALE; FEMUR NECK; GENE FREQUENCY; GENES, REPORTER; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LUCIFERASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 33144479730     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.051013     Document Type: Article

References (24)

1. Ralston S 1999 The genetics of osteoporosis. Bone 25:85-86.
2. Schinke T, Karsenty G 1999 Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse osteocalcin promoters. J Biol Chem 274:30182-30189.
3. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell RI, Stamp GWH, Beddington RSP, Mundlos S, Olsen BR, Selby PB, Owen MJ 1997 CBFA1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
4. Stock M, Otto F 2005 Control of RUNX2 isoform expression: The role of promoters and enhancers. J Cell Biochem 95:506-517.
5. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K, Ito Y 1993 PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci USA 90:6859-6863.
6. Stewart M, Terry A, Hu M, O'Hara M, Bylth K, Baxter E, Cameron E, Onions DE, Neil JC 1997 Proviral insertions induce the expression of bone specific isoforms of PEBP2aA (CBFA1): Evidence of a new myc collaborating oncogene. Proc Natl Acad Sci USA 94:8646-8651.
7. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:677-680.
8. Xiao ZS, Thomas R, Hinson TK, Quarles LD 1998 Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene 214:187-197.
9. Shui C, Spelsberg TC, Riggs BL, Khosla S 2003 Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 18:213-221.
10. Xiao ZS, Simpson L, Quarles LD 2003 IRES-dependent expressional control of Cbfa1/Runx2 expression. J Cell Biochem 88:493-505.
11. Terry A, Kilbey A, Vaillant F, Stewart M, Jenkins A, Cameron E, Neil JC 2004 Conservation and expression of an alternative 3-prime exon of Runx2 encoding a novel proline-rich C-terminal domain. Gene 336:115-125.
12. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson R, Gao Y, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
13. Otto F, Kanegane H, Mundlos S 2002 Mutations in the RUNX2 gene in patients with cleidocranial dysplasia. Hum Mutat 19:209-216.
14. Vaughan T, Pasco J, Kotowicz M, Nicholson G, Morrison NA 2002 Alleles of the RUNX2/CBFA1 gene are associated with differences in bone mineral density and risk of fracture. J Bone Miner Res 17:1527-1534.
15. Vaughan T, Reid D, Morrison NA, Ralston S 2004 RUNX2 alleles associated with BMD in Scottish women; interaction of RUNX2 alleles with menopausal status and body mass index. Bone 34:1029-1036.
16. Pasco JA, Henry MJ, Gaudry T, Nicholson GC, Kotowicz MA 1999 Identification of incident fractures: The Geelong osteoporosis study. Aust NZJ Med 29:203-206.
17. Henry MJ, Pasco JA, Seeman E, Nicholson GC, Kotowicz MA 2000 Prevalence of osteoporosis in Australian women: Geelong osteoporosis study. J Clin Densitom 3:261-268.
18. Sanders KM, Pasco JA, Ugoni AM, Nicholson GC, Seeman E, Martin TJ, Skoric B, Panahi S, Kotowicz MA 1998 The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: The Geelong Osteoporosis Study. J Bone Miner Res 13:1337-1342.
19. Sanders KM, Seeman E, Ugoni AM, Pasco JA, Martin TJ, Skoric B. Nicholson GA, Kotowicz MA 1999 Age- and gender-specific rate of fractures in Australia: A population-based study. Osteoporos Int 10:240-247.
20. Morrison NA, Eisman JA 1993 Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin gene. J Bone Miner Res 8:969-975.
21. Ding K, Zhou K, He F, Shen Y 2003 LDA: A Java-based linkage disequilibrium analyzer. Bioinformatics 19:2147-2148.
22. Schug J, Overton GC 1997 TESS: Transcription element search software. Available online at http://www.cbil.upenn.edu/tess. Accessed November 16, 2004.
23. Xiao ZS, Hjelmeland AB, Quarles LD 2004 Selective deficiency of the "bone-related" Runx2-II unexpectedly preserves osteoblast-mediated skefetogenesis. J Biol Chem 279:20307-20313.
24. Xiao ZS, Awad HA, Liu S, Mahlios J, Zhang S, Guilak F, Mayo MS, Quarles LD 2005 Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice. Dev Biol 283: 345-356.